tb 500 and bpc 157 oral BPC-157 / TB-500 capsules BPC-157 & TB-500 Blend For
Description
No FDA status Not FDA-approved Compound Semaglutide Mechanism GLP-1 receptor agonist
Protocols generally run for 12 to 26 weeks, with metabolic labs monitored at baseline, 8 weeks, and periodically thereafter
This was a recommendation both in the James Lind Alliance Priority Setting Partnership which PAS initiated and funded and in the NICE Guideline on B12 Deficiency which PAS initiated
Label every vial: peptide name, concentration (mg/mL or mcg/mL), reconstitution date, lot number, and operator initials
